2019 Nominees

Register to vote

Nominated For
9 Votes Share
Lifespot Health has achieved first sales of its medical cannabis inhaler to Australian patients under the Therapeutic Goods Administration’s (TGA) Special Access Scheme (SAS). The company has officially launched its Medihale sealed pod inhaler device in Melbourne, with the first patient group using the device, pod and third-party EC Pharma’s cannabidiol e-liquid.

Supporting Photo